APOE and Alzheimer disease: More recently, polygenic approaches [12, 13] have been developed that yield genetic risk scores incorporating AD associated single nucleotide polymorphisms, and these show some promise in identifying genetic risk for AD beyond APOE, even though the results were mixed in predicting AD conversion in participants with Mild Cognitive Impairment.